Reports Q3 revenue $73.09M, consensus $76.01M. “In the third quarter, we delivered solid gross margin expansion, drove continued improvements in profitability, and achieved double-digit growth in both our commercial and VA lymphedema channels,” said Sheri Dodd, President and Chief Executive Officer of Tactile Medical. “Operationally, we advanced key pillars of our commercial strategy, including launching our next-generation lymphedema therapy platform and announcing the publication of a positive new data set among Veterans.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCMD:
- Tactile Systems Technology (TCMD) Q3 Earnings Cheat Sheet
- These 2 ‘Strong Buy’ Medical Device Stocks Are Poised for Growth, Says Analyst
- Tactile Systems launches next-generation Nimbl platform
- Starbucks upgraded, Hershey downgraded: Wall Street’s top analyst calls
- Tactile Systems initiated with a Buy at B. Riley